Expression of HPV16 E5 down-modulates the TGFbeta signaling pathway

Molecular Cancer

Volumn 12, Issue 1, 2013, Pages

  French, Deborah ^a,b   Belleudi, Francesca ^a   Mauro, Maria Vittoria ^a   Mazzetta, Francesca ^a   Raffa, Salvatore ^a,b   Fabiano, Vincenza ^a   Frega, Antonio ^b   Torrisi, Maria Rosaria ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

HPV16 E5; Human papillomavirus; SMAD; TGF signaling; TGF RII

Indexed keywords

SMAD2 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HUMAN PAPILLOMAVIRUS TYPE 16; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM GRADING; ONCOGENE PROTEINS, VIRAL; RNA, MESSENGER; SIGNAL TRANSDUCTION; SMAD PROTEINS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

HUMAN PAPILLOMAVIRUS;

EID: 84877018881     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-12-38     Document Type: Article

References (24)

1. Doorbar J. Papillomavirus life cycle organization and biomarker selection. Dis Markers 2007, 23:297-313.
2. Woodman CB, Collins SI, Young LS. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 2007, 7:11-22. 10.1038/nrc2050, 17186016.
3. Stanley M. Pathology and epidemiology of HPV infection in females. Gynecol Oncol 2010, 117:S5-S10. 10.1016/j.ygyno.2010.01.024, 20304221.
4. Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 2010, 10:550-560. 10.1038/nrc2886, 20592731.
5. Lorenzon L, Mazzetta F, Venuti A, Frega A, Torrisi MR, French D. In vivo HPV 16 E5 mRNA: expression pattern in patients with squamous intra-epithelial lesions of the cervix. J Clin Virol 2011, 52:79-83. 10.1016/j.jcv.2011.06.007, 21767984.
6. Venuti A, Paolini F, Nasir L, Corteggio A, Roperto S, Campo MS, Borzacchiello G. Papillomavirus E5: the smallest oncoprotein with many functions. Mol Cancer 2011, 10:140. 10.1186/1476-4598-10-140, 3248866, 22078316.
7. Belleudi F, Leone L, Purpura V, Cannella F, Scrofani C, Torrisi MR. HPV16 E5 affects the KGFR/FGFR2b-mediated epithelial growth through alteration of the receptor expression, signaling and endocytic traffic. Oncogene 2011, 30:4963-4976. 10.1038/onc.2011.203, 21625213.
8. Drabsch Y, ten Dijke P. TGF-beta signalling and its role in cancer progression and metastasis. Cancer Metastasis Rev 2012, 31:553-568. 10.1007/s10555-012-9375-7, 22714591.
9. Zi Z, Chapnick DA, Liu X. Dynamics of TGF-beta/Smad signaling. FEBS Lett 2012, 586:1921-1928. 10.1016/j.febslet.2012.03.063, 22710166.
10. Baritaki S, Sifakis S, Huerta-Yepez S, Neonakis IK, Soufla G, Bonavida B, Spandidos DA. Overexpression of VEGF and TGF-beta1 mRNA in Pap smears correlates with progression of cervical intraepithelial neoplasia to cancer: implication of YY1 in cervical tumorigenesis and HPV infection. Int J Oncol 2007, 31:69-79.
11. Peghini BC, Abdalla DR, Barcelos AC, Teodoro L, Murta EF, Michelin MA. Local cytokine profiles of patients with cervical intraepithelial and invasive neoplasia. Hum Immunol 2012, 73:920-926. 10.1016/j.humimm.2012.06.003, 22749886.
12. Deng W, Tsao SW, Kwok YK, Wong E, Huang XR, Liu S, Tsang CM, Ngan HY, Cheung AN, Lan HY. Transforming growth factor beta1 promotes chromosomal instability in human papillomavirus 16 E6E7-infected cervical epithelial cells. Cancer Res 2008, 68:7200-7209. 10.1158/0008-5472.CAN-07-6569, 18757436.
13. Guasch G, Schober M, Pasolli HA, Conn EB, Polak L, Fuchs E. Loss of TGFbeta signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia. Cancer Cell 2007, 12:313-327. 10.1016/j.ccr.2007.08.020, 2424201, 17936557.
14. Wakefield LM, Stuelten C. Keeping order in the neighborhood: new roles for TGFbeta in maintaining epithelial homeostasis. Cancer Cell 2007, 12:293-295. 10.1016/j.ccr.2007.10.002, 17936552.
15. Diaz-Chavez J, Hernandez-Pando R, Lambert PF, Gariglio P. Down-regulation of transforming growth factor-beta type II receptor (TGF-betaRII) protein and mRNA expression in cervical cancer. Mol Cancer 2008, 7:3. 10.1186/1476-4598-7-3, 2248208, 18184435.
16. Boccardo E, Lepique AP, Villa LL. The role of inflammation in HPV carcinogenesis. Carcinogenesis 2010, 31(11):1905-1912. 10.1093/carcin/bgq176, 20819779.
17. Rojas A, Padidam M, Cress D, Grady WM. TGF-beta receptorlevels regulate the specificity of signaling pathway activation and biological effects of TGF-beta. Biochim Biophys Acta 2009, 1793(7):1165-1173. 10.1016/j.bbamcr.2009.02.001, 2700179, 19339207.
18. Buschke S, Stark HJ, Cerezo A, Pratzel-Wunder S, Boehnke K, Kollar J, Langbein L, Heldin CH, Boukamp P. A decisive function of transforming growth factor-β/SMAD signaling in tissue morphogenesis and differentiation of human HaCaT keratinocytes. Mol Biol Cell 2011, 22(6):782-794. 10.1091/mbc.E10-11-0879, 3057703, 21289094.
19. Stanley MA, Browne HM, Appleby M, Minson AC. Properties of a non-tumorigenic human cervical keratinocyte cell line. Int J Cancer 1989, 43:672-676. 10.1002/ijc.2910430422, 2467886.
20. Pett MR, Alazawi WO, Roberts I, Dowen S, Smith DI, Stanley MA, Coleman N. Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes. Cancer Res 2004, 64:1359-1368. 10.1158/0008-5472.CAN-03-3214, 14973079.
21. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988, 106:761-771. 10.1083/jcb.106.3.761, 2115116, 2450098.
22. Oelze I, Kartenbeck J, Crusius K, Alonso A. Human papillomavirus type 16 E5 protein affects cell-cell communication in an epithelial cell line. J Virol 1995, 69:4489-4494. 189191, 7769709.
23. Ashrafi GH, Haghshenas MR, Marchetti B, O'Brien PM, Campo MS. E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I. Int J Cancer 2005, 113:276-283. 10.1002/ijc.20558, 15386416.
24. Wetherill LF, Holmes KK, Verow M, Muller M, Howell G, Harris M, Fishwick C, Stonehouse N, Foster R, Blair GE, Griffin S, Macdonald A. High-risk human papillomavirus E5 oncoprotein displays channel-forming activity sensitive to small-molecule inhibitors. J Virol 2012, 86:5341-5351. 10.1128/JVI.06243-11, 3347351, 22357280.